February 28, 2025

New Publication from CeMOS: Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer

New Publication from CeMOS: Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer

Müller, E.; Enzlein, T.; Niemeyer, D.; von Ammon, L.; Stumpo, K.; Biber, K.; Klein, C.; Hopf, C. Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer. Pharmaceuticals 202518, 252. https://doi.org/10.3390/ph18020252

Abstract

Amyloid-β (Aβ) plaque deposits in the brain are a hallmark of Alzheimer’s disease (AD) neuropathology. Plaques consist of complex mixtures of peptides like Aβ1–42 and characteristic lipids such as gangliosides, and they are targeted by reactive microglia and astrocytes. Background: In pharmaceutical research and development, it is a formidable challenge to contextualize the different biomolecular classes and cell types of the Aβ plaque microenvironment in a coherent experimental workflow on a single tissue section and on a benchtop imaging reader. Methods: Here, we developed a workflow that combines lipid MALDI mass spectrometry imaging using a vacuum-stable matrix with histopathology stains and with the MALDI HiPLEX immunohistochemistry of plaques and multiple protein markers on a benchtop imaging mass spectrometer. The three data layers consisting of lipids, protein markers, and histology could be co-registered and evaluated together. Results: Multimodal data analysis suggested the extensive co-localization of Aβ plaques with the peptide precursor protein, with a defined subset of lipids and with reactive glia cells on a single brain section in APPPS1 mice. Plaque-associated lipids like ganglioside GM2 and phosphatidylinositol PI38:4 isoforms were readily identified using the tandem MS capabilities of the mass spectrometer. Conclusions: Altogether, our data suggests that complex pathology involving multiple lipids, proteins and cell types can be interrogated by this spatial multiomics workflow on a user-friendly benchtop mass spectrometer.

Our latest News

discover more
Contracts signed for Heidelberg-Mannheim hospital network

Contracts signed for Heidelberg-Mannheim hospital network

It’s now official: the alliance between the two university hospitals in Heidelberg and Mannheim can start as planned on January 1 and begin its work. Press release from the Baden-Württemberg Ministry of Science, Research, and the Arts. Full Text in German below. Verträge zum Klinikverbund Heidelberg-Mannheim unterzeichnet Nun ist es offiziell: Der Verbund zwischen den […]

Cystic fibrosis research: AI-assisted evaluation of MRI images in chronic rhinosinusitis

Cystic fibrosis research: AI-assisted evaluation of MRI images in chronic rhinosinusitis

Persistent inflammation of the paranasal sinuses, chronic rhinosinusitis, is a common comorbidity in cystic fibrosis and significantly impairs quality of life. The working group led by Dr. Niclas Hagen, Institute for Medical Informatics at Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital, is currently developing a method that uses AI to contribute to the […]

New Research Group Leader at the Max Planck Institute for Medical Research

New Research Group Leader at the Max Planck Institute for Medical Research

In March 2026, Kevin Jahnke will establish a research group on ‘Biomembrane Engineering’ at the new Heilbronn site of the Max Planck Institute for Medical Research. Its focus will be on engineering synthetic lipid nano- and microstructures, with the aim of investigating the biophysics of both cells and lipid vesicles.  Connecting biophysical insights with biotechnological […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp